Injective (INJ) is trading at $4.90, with technical indicators flashing oversold and short sellers piling in from both retail and whale accounts. The setup has traders watching for a potential short squeeze that could drive the token to $5.25 — but only if bulls can reclaim the $5.07 level first.
Oversold stochastics draw attention
INJ's stochastic oscillator has dipped into oversold territory, a reading that often precedes a bounce. The signal is far from a guarantee in crypto markets, but it adds to the narrative that selling pressure may be exhausted in the near term. The token has been sliding in recent sessions, and the oversold condition suggests the move lower might be overdone.
Short positioning gets crowded
The bigger story might be the short side. Positioning data shows short bets are densely packed across both retail traders and large whale accounts. That kind of crowding creates the raw material for a squeeze: if prices start rising, shorts rush to cover, fueling further gains. The $5.25 target represents a roughly 7% gain from current levels — a realistic move if the squeeze materializes.
But crowded trades can unwind in either direction. If the squeeze fails to ignite, the same concentrated short interest could keep a lid on any rally, as sellers remain ready to reload.
The $5.07 line in the sand
Bulls need to reclaim $5.07 to confirm momentum has shifted. That level has acted as both support and resistance in recent trading. A clean break above it would likely trigger stop-losses from short sellers and attract fresh buying. Without that push, INJ risks sliding to $4.58 — a 6.5% drop that would take out the oversold bounce thesis entirely.
The next few sessions will show whether the technical setup has enough fuel to spark a squeeze, or whether bearish pressure will drive INJ lower first.
